Manulife (Manufacturers Life Insurance)
BHVN

Manulife (Manufacturers Life Insurance)’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History

Manulife (Manufacturers Life Insurance)’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-24,238
Closed -$3.66M – 3059
2022
Q3 		$3.66M Buy
24,238
+103
+0.4% +$15.3K ﹤0.01% 1178
2022
Q2 		$3.52M Buy
24,135
+2,282
+10% +$291K ﹤0.01% 1252
2022
Q1 		$2.59M Sell
21,853
-5,215
-19% -$650K ﹤0.01% 1439
2021
Q4 		$3.73K Sell
27,068
-345
-1% -$43.9K ﹤0.01% 1347
2021
Q3 		$3.81M Sell
27,413
-1,842
-6% -$230K ﹤0.01% 1331
2021
Q2 		$2.84M Buy
29,255
+3,113
+12% +$253K ﹤0.01% 1480
2021
Q1 		$1.79M Sell
26,142
-1,624
-6% -$131K ﹤0.01% 1599
2020
Q4 		$2.38M Buy
27,766
+1,020
+4% +$86.4K ﹤0.01% 1466
2020
Q3 		$1.74M Sell
26,746
-287
-1% -$18.8K ﹤0.01% 1459
2020
Q2 		$1.87M Buy
27,033
+1,700
+7% +$90.5K ﹤0.01% 1414
2020
Q1 		$862K Buy
25,333
+2,894
+13% +$132K ﹤0.01% 1580
2019
Q4 		$1.03M Sell
22,439
-366
-2% -$18.1K ﹤0.01% 1668
2019
Q3 		$947K Buy
22,805
+3,003
+15% +$127K ﹤0.01% 1674
2019
Q2 		$867K Buy
19,802
+258
+1% +$14.5K ﹤0.01% 1719
2019
Q1 		$1.01M Buy
19,544
+2,178
+13% +$94.1K ﹤0.01% 1690
2018
Q4 		$642K Sell
17,366
-659
-4% -$23.8K ﹤0.01% 1828
2018
Q3 		$677K Sell
18,025
-1,646
-8% -$60.5K ﹤0.01% 2070
2018
Q2 		$777K Sell
19,671
-3,188
-14% -$101K ﹤0.01% 2049
2018
Q1 		$589K Buy
22,859
+14,873
+186% +$445K ﹤0.01% 2219
2017
Q4 		$215K Hold
7,986
– – ﹤0.01% 2946
2017
Q3 		$298K Buy
7,986
+181
+2% +$5.49K ﹤0.01% 2668
2017
Q2 		$196K Buy
+7,805
New +$180K ﹤0.01% 3028

Other funds holding BHVN

LIP
Liontrust Investment Partners London, United Kingdom $5.86B AUM 23.75% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return

Manulife (Manufacturers Life Insurance)'s BHVN Position: Q4 2022 in Review

Manulife (Manufacturers Life Insurance) sold out of Biohaven Pharmaceutical Holding Company Ltd. (BHVN) in Q4 2022, closing a stake of 24,238 shares — an estimated $3.66M sold.

Manulife (Manufacturers Life Insurance) first reported a position in BHVN in Q2 2017 and held it in 22 quarters. The position peaked at $3.81M in Q3 2021. 7 funds tracked by Wall St. Rank hold BHVN as of Q4 2022.

  • Manulife (Manufacturers Life Insurance) reported no remaining Biohaven Pharmaceutical Holding Company Ltd. position as of Q4 2022 after selling out during the quarter.
  • Manulife (Manufacturers Life Insurance) sold 24,238 Biohaven Pharmaceutical Holding Company Ltd. shares in Q4 2022, an estimated $3.66M.
  • Manulife (Manufacturers Life Insurance) first reported a position in Biohaven Pharmaceutical Holding Company Ltd. in Q2 2017 and held it in 22 quarters.
  • Manulife (Manufacturers Life Insurance)'s Biohaven Pharmaceutical Holding Company Ltd. position peaked at $3.81M in Q3 2021.
  • 7 funds tracked by Wall St. Rank held Biohaven Pharmaceutical Holding Company Ltd. as of Q4 2022.

Based on Manulife (Manufacturers Life Insurance)'s 13F filing for Q4 2022, filed 13 Feb 2023.